Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$27.5K Sell
1,505
-233
-13% -$5.54K ﹤0.01% 2752
2026
Q2
$36K Sell
1,738
-2,070
-54% -$48.8K ﹤0.01% 2527
2026
Q1
$86.6K Buy
3,808
+1,953
+105% +$46.2K ﹤0.01% 1793
2025
Q4
$49.4K Buy
1,855
+1,446
+354% +$42.7K ﹤0.01% 2086
2025
Q3
$12.4K Sell
409
-628
-61% -$19K ﹤0.01% 2775
2025
Q2
$32.5K Sell
1,037
-133
-11% -$4.4K ﹤0.01% 2197
2025
Q1
$44.7K Buy
1,170
+692
+145% +$29.4K ﹤0.01% 1872
2024
Q4
$21K Buy
478
+199
+71% +$8.74K ﹤0.01% 2244
2024
Q3
$12K Sell
279
-519
-65% -$23.1K ﹤0.01% 2372
2024
Q2
$36.1K Sell
798
-287
-26% -$14.9K ﹤0.01% 1430
2024
Q1
$67.8K Buy
1,085
+180
+20% +$10.8K 0.01% 841
2023
Q4
$53.1K Buy
+905
New +$45.1K 0.01% 855

Other funds holding ENOV

GAMMA Investing's ENOV Position: Q3 2026 in Review

GAMMA Investing reduced its Enovis (ENOV) stake by 13% in Q3 2026, selling an estimated $5.54K and leaving 1,505 shares worth $27.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2752.

GAMMA Investing first reported a position in ENOV in Q4 2023 and has held it in 12 quarters since. The position peaked at $86.6K in Q1 2026. 5 funds tracked by Wall St. Rank hold ENOV as of Q3 2026.

  • GAMMA Investing held 1,505 shares of Enovis worth $27.5K as of Q3 2026.
  • GAMMA Investing sold 233 Enovis shares in Q3 2026, an estimated $5.54K.
  • Enovis made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2752 holding.
  • GAMMA Investing first reported a position in Enovis in Q4 2023 and has held it in 12 quarters since.
  • GAMMA Investing's Enovis position peaked at $86.6K in Q1 2026.
  • 5 funds tracked by Wall St. Rank held Enovis as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.